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Abstract
Background: Despite the importance of identifying co-occurring psychiatric disorders in
substance abuse treatment programs, there are few appropriate and validated instruments available
to substance abuse treatment staff to conduct brief screen for these conditions. This paper
describes the development, implementation and validation of a brief screening instrument for
mental health diagnoses and trauma among a diverse sample of Black, Hispanic and White women
in substance abuse treatment. With input from clinicians and consumers, we adapted longer
existing validated instruments into a 14 question screen covering demographics, mental health
symptoms and physical and sexual violence exposure. All women entering treatment (methadone,
residential and out-patient) at five treatment sites were screened at intake (N = 374).
Results: Eighty nine percent reported a history of interpersonal violence, and 70% reported a
history of sexual assault. Eighty-eight percent reported mental health symptoms in the last 30 days.
The screening questions administered to 88 female clients were validated against in-depth
psychiatric diagnostic assessments by trained mental health clinicians. We estimated measures of
predictive validity, including sensitivity, specificity and predictive values positive and negative.
Screening items were examined multiple ways to assess utility. The screen is a useful and valid
proxy for PTSD but not for other mental illness.
Conclusion: Substance abuse treatment programs should incorporate violence exposure
questions into clinical use as a matter of policy. More work is needed to develop brief screening
tools measures for front-line treatment staff to accurately assess other mental health needs of
women entering substance abuse treatment
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Women present for substance abuse treatment with a
diverse set of complex medical and social problems,
including mental health disorders and psychological dis-
tress, high rates of history of trauma and interpersonal
violence, medical problems, few vocational skills, low
income, and substantial addiction severity [1-4]. General
data for men and women seeking treatment for alcohol
and cocaine problems show that 56–78% of clients have
a lifetime psychiatric disorder and 65–73.5% have a cur-
rent disorder in addition to substance use [5,6]. Estimates
of the prevalence of diagnosed post-traumatic stress disor-
der (PTSD) range from 20 to 60% among women in sub-
stance abuse treatment [7-9]. Even more common is
exposure to interpersonal violence, which we define in
this paper as physical or sexual violence occurring during
childhood, and/or adulthood. For example, it has been
reported that more than 70% of women in substance
abuse treatment report a history of childhood sexual
abuse [1,4,10,11].
Among people in substance abuse treatment the co-occur-
rence of psychiatric distress or disorder has been associ-
ated with lower social functioning, decreased quality of
life and poorer general health [12,13]. In addition people
with co-occurring psychiatric disorders in substance abuse
treatment have been found to have worse treatment
adherence, and worse substance abuse treatment out-
comes than people without co-occurring psychiatric dis-
orders [14-16]. Among women in substance abuse
treatment studies have reported that women with addic-
tion disorders and co-occurring PTSD are more likely to
have additional problems such as homelessness, criminal
activity, and unemployment than peers without PTSD
[5,17,18]. These social problems, along with the addi-
tional psychopathology among women in substance
abuse treatment, have been associated with higher levels
of impairment [5] and poor substance abuse treatment
outcomes [1,19-24]. Importantly, treatments for psychiat-
ric disorders developed for non-substance abusing
patients are effective both for treating the psychiatric
symptoms and for improving substance abuse treatment
outcomes [25] Therefore detection of co-occurring prob-
lems among women in entering substance abuse treat-
ment allows for the earlier referral to appropriate
treatment, and thus may positively impact treatment out-
comes.
This problem of co-occurring psychiatric disorders creates
tremendous challenges for substance abuse treatment
counselors and other front-line substance abuse treatment
staff who may not be adequately trained to assess and
treat trauma and mental health problems. In most sub-
stance abuse treatment programs full psychiatric assess-
ments remain difficult to administer due to prohibitive
cost and inadequate staffing despite high prevalence of co-
occurring psychiatric disorders. However the evidence
shows that more than half of the women with whom sub-
stance abuse counselors work are struggling with co-
occurring psychiatric disorders. The lack of a practical,
brief, validated screen to identify potential problems
presents one barrier to improving identification of clients
with needs for referral to mental health and trauma-spe-
cific programs.
A brief screen should ideally have a low false negative rate
since the consequences of failing to identify a woman in
need of mental health services with a substance abuse
treatment setting are many. Ideally it will also produce few
false positives as the resources available to substance
abuse treatment facilities for further assessment and treat-
ment are highly limited. Although there are existing
instruments that assess mental health status or traumatic
events, each one has different limitations for use in this
setting. Kessler and colleagues developed a 6 question
instrument, the K6, for inclusion in epidemiological stud-
ies to estimate the prevalence of serious mental illness
(DSM-IV diagnosis in past 12 months accompanied by
serious impairment) [26]. It purposely excluded impair-
ments from substance use disorders, so its value in a sub-
stance abuse treatment setting is unclear. As well, it has
not been tested in clinical settings where there is an
increased prevalence of mental illness. Other instruments
designed for research purposes, such as the Diagnostic
Interview Schedule (DIS) [27], Structured Clinical Inter-
view for DSM (SCID) [28] and Composite International
Diagnostic Interview- Short form (CIDI-SF) [29], are
either too long or require trained interviewers, making
them impractical for use by front-line substance abuse
treatment staff. Symptom checklists such as the Brief
Symptom Inventory (BSI) are limited by their self-report
of specific symptoms within the past week. In addition the
BSI is expensive to administer and requires a high level of
training for reliable use [30]. Zimmerman and colleagues
developed the 139 question Psychiatric Diagnostic
Screening Questionnaire for self-administration by clients
in mental health outpatient settings. It includes 13 sub-
scales on common psychiatric diagnoses, including com-
mon disorders such as depression, PTSD, anxiety,
psychosis, and eating disorders[31]. Subsequently, the
developers showed it to be valid among clients with sub-
stance use disorders[32]. The scoring algorithm requires
computation of each item in the scale, and may be cum-
bersome for use[33]. Another measure of multiple psychi-
atric diagnoses, the MINI, is a 15–20 minute structured
interview for multiple psychiatric disorders developed for
psychiatric outpatient as well as general medical popula-
tions[34]. A short (5 minute) version, a subset of ques-
tions on depression, anxiety, eating disorders and
substance abuse was developed for primary care, althoughPage 2 of 9
(page number not for citation purposes)
Substance Abuse Treatment, Prevention, and Policy 2006, 1:26 http://www.substanceabusepolicy.com/content/1/1/26was not validated in that form. The shortened MINI as
well as two other similar instruments, the PRIME MD [35]
and the SDDS-PC [36] have not been validated for use in
substance abuse treatment settings. In fact, the presence of
substance use disorders may interfere with the accuracy of
some screening tests.
In addition to problems with screening generally for men-
tal health disorders, currently available screens for post-
traumatic stress disorder, an important comorbid
condition for women in substance abuse treatment
include 15 or more questions, are generally designed for
research purposes, involve a complicated scoring algo-
rithm, are proprietary and/or require a level of training
which serves as a barrier to their use in substance abuse
treatment settings [37-44].
Thus, one barrier to more comprehensive screening for co-
occurring problems among women in substance abuse
treatment is the lack of a valid screening tool that can be
easily and quickly administered by substance abuse coun-
selors.
In this paper we describe our efforts to develop, imple-
ment, and validate of a brief screening instrument
designed to help front-line substance abuse treatment
staff, primarily intake and substance abuse counselors,
identify potential problems in women seeking residential
and outpatient substance abuse treatment. The Boston
Consortium of Services for Families in Recovery (BCSFR)
Screen is designed specifically to be used by front-line sub-
stance abuse treatment staff to screen for possible PTSD
and other mental health disorders. We examine whether
the mental health screening items predict psychiatric diag-
noses and whether asking women about their trauma his-
tories might serve as a screen for PTSD among women in
substance abuse treatment.
Materials and methods
Development of co-occurring disorders screen
The Boston Consortium of Services for Families in Recov-
ery (BCSFR), a program of the Boston Public Health Com-
mission, was the Boston site (Hortensia Amaro, principal
investigator) of the SAMHSA-funded Women, Co-occur-
ring Disorders and Violence Study [45]. The BCSFR was
designed as an intervention to incorporate trauma and
mental health treatment into existing outpatient and resi-
dential substance abuse treatment programs [46]. The
BCSFR was a multi-site, multi-agency collaboration
among providers of services, consumers, researchers and
other stakeholders working with women in urban public
substance abuse treatment. Soon into the implementation
of the BCSFR intervention, the group identified a gap in
the resources available to the front-line treatment staff:
the lack of an easy to administer, brief screen to quickly
identify multiple problems women faced as they entered
substance abuse treatment. Thus, a committee composed
of service providers, researchers, and client representatives
developed screening questions for use in both substance
abuse treatment and other health care settings to identify
which clients might need further assessment by mental
health professionals. The instrument domains included
the following: demographics, mental health symptoms,
interpersonal violence exposure, substance abuse, food
and housing vulnerability, parenting stress, and child
exposure to violence. For each area, a literature search was
conducted to identify validated publicly available instru-
ments. To minimize the length of the entire instrument,
the development group examined each existing instru-
ment for the fewest number of questions possible. In
some cases, the group, with input from specialty profes-
sionals, adapted or combined existing questions.
The BCSFR Screen was developed over six months with
iterative input from clients, clinicians (substance abuse,
mental health, and medical), and researchers. Further
revisions were made following a pilot period at each of
the participating substance abuse treatment sites. During
pilot testing, intake counselors at four participating sub-
stance abuse treatment programs were trained in adminis-
tration of the screen and were provided materials for
appropriate referral and assistance. These sites represented
multiple modalities of substance abuse treatment (e.g.,
outpatient, methadone, and residential programs). Each
site administered the screen to 5 new clients. Subjective
feedback from substance abuse counselors revealed a
short time (approximately 5 minutes) to administer the
screen and ready acceptance by clients. Minor revisions to
the instrument were made based on feedback from the
pilot. The BCFSR Screen was translated into Spanish and
back translated into English. Bilingual substance abuse
counselors administered the Spanish version to clients
who preferred to speak Spanish.
The BCSFR Screen was then administered during routine
assessment by clinical staff at each site with every new cli-
ent. Copies of the BCSFR screen were kept in the client's
record and used to guide treatment planning and clinical
care. For data collection purposes, each client's identity
was masked by an identification code used by the State
Department of Substance Abuse Treatment in tracking cli-
ents in publicly sponsored treatment programs. The
screen results were tabulated by the Boston Public Health
Commission's data management program as part of qual-
ity assurance and programmatic information.
Content areas and sources
Mental health symptoms
Mental health symptom questions were created to cover 4
domains deemed important by the mental health profes-Page 3 of 9
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psychosis, and suicidality. The question on depressed
mood was adapted from 2 separate questions on the orig-
inal PRIME-MD [35]. The other questions were developed
from expert input by mental health professionals and
adjusted based on client-representative and service-pro-
vider input.
Trauma exposure
Trauma questions included queries on lifetime intimate
partner violence, sexual assault, and childhood exposure
to violence. The 3 questions on lifetime intimate partner
violence were taken directly from STaT, a 3-question
screen [47]. This 3 question screening tool for lifetime
intimate partner violence has been validated in emergency
department and outpatient medical settings, but not in
substance misusing or treatment populations.
Questions on childhood physical and sexual abuse were
adapted from the Washington State Behavioral Risk Factor
Surveillance Survey [48]. The wording of these 2 questions
remained the same except for a decrease in age from 18 to
13 years. The question on lifetime sexual abuse was taken
from a Veterans Administration Trauma questionnaire.
Poverty
A total of 2 questions were selected from a 10-question
instrument assessing poverty [49], which focused on diffi-
culty obtaining food and housing in the prior 2 years.
Parental stress and children at risk
The 3 questions designed to assess parenting stress and
children's witnessing of violence were constructed with
input from clinicians with expertise in pediatrics and
childhood trauma. Clinicians and client representatives
made substantial changes to the wording of these ques-
tions during the review process to minimize potential
offensiveness to clients.
Validation of the BCSFR screen
Three bilingual clinicians (2 at the Doctoral level and 1 at
the Masters level) blinded to the BCSFR Screen results per-
formed a semi-structured clinical diagnostic interview for
mental health diagnoses including PTSD on 88 partici-
pants participating in the overall study intervention, all of
whom were clients at participating substance abuse treat-
ment programs. Participants were assessed in either Eng-
lish or Spanish, depending on preferred language. The
resulting diagnoses were compared with the screen results
for the sub-sample of 88 women. The Institutional Review
Boards at Boston University Medical Center, New England
Research Institutes (NERI), and Northeastern University
approved the BCSFR study.
Analysis
Descriptive analyses were performed on data for the first
374 clients screened during implementation of the BCSFR
Screen. To validate the BCSFR Screen against the criterion
standard for the diagnostic interview, we conducted addi-
tional analyses on the subsample of 88 women who
received diagnostic assessments. Pearson Chi-square and
2-sided Student's T-tests were used to compare the charac-
teristics of the women who were only screened and the
validation samples. We first examined the inter-item reli-
ability among the screening questions in the subsample.
Cronbach's alpha was used to measure intercorrelations
among the mental health items and the PTSD items. We
next examined the relationship between screening items
and diagnostic interview results. We examined the predic-
tive value of the mental health symptoms screening items
for predicting mental health diagnoses and the predictive
value of the trauma history items for a diagnosis of PTSD.
Ninety-five percent confidence intervals were constructed
for sensitivity, specificity, positive and negative predictive
values, and false positive and negative estimates [50].
Fisher's Exact tests were used to assess non-random asso-
ciation between the test and diagnostic results. Receiver
operating characteristic (ROC) curve analysis was used to
compute the c-statistic, the area under the ROC curve,
which measures test performance. Further analyses of the
predictive value of mental health symptoms screening
questions were conducted among groups stratified by age
at exposure to violence (childhood and adult, adult only,




Of the 374 participants screened, the mean age was 36
years (sd = 8; range 18–67), with 31% Hispanic, 29%
White, 34% Black, and 6% other. Thirty-nine percent
reported at least 1 time during the past year when they
were not able to obtain needed food, and 53% reported
difficulty affording a place to live in the past 2 years.
Eighty-eight percent of clients were mothers, of whom
33% had children with physical or behavioral problems
for whom they found it difficult to care. A sub-sample of
88 women were administered both the screen and diag-
nostic assessment were similar to the remaining woman
in our study sample. However, the women who were
screened (n = 286) differed statistically from those in the
validation sample only in race/ethnicity,, type of treat-
ment, and, proportion who had children. In particular,
the screening sample had a higher proportion of white
women (33% vs 16%) and a lower proportion of His-
panic women (26% vs 48%). They were also more likely
to be in a methadone treatment center (57% vs. 11%) and
less likely to be in residential treatment (17% vs. 65%)
(Table 1).Page 4 of 9
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eight percent in the total sample reported at least 1 mental
health symptom in the past 30 days, with rates highest for
feeling depressed or anxious. A full 89% of women
reported a history of intimate partner violence, 70%
reported a history of sexual assault, and 61% reported that
their history of abuse began when they were under the age
of 13 years. Statistical comparisons suggest that the
women in the screening and validation samples differed
only on the item concerning threat of violence by a part-
ner, with more women in the validation sample reporting
this experience (86 vs. 75%).
Validation of the mental health symptoms screening items
Using Fisher's Exact test, the relationship between each
mental health symptom screening item and the appropri-
ate diagnosis was tested. None of the mental health symp-
toms screening items were significant predictors of
specific diagnoses, either alone or in combination with
other mental health screening items. Next, a test of associ-
ation was conducted for each mental health symptom
screening item as well as for various combinations of
screening items, each with "any psychiatric diagnoses;" no
significant associations were found. Finally, the mental
health symptom screening items were analyzed as counts
(1–4 symptoms reported). This did not increase the power
of the screening questions to identify women at risk for
co-occurring psychiatric disorder(s).
Validation of the trauma history screening items for PTSD
The Cronbach's alpha coefficient for the 6 trauma history
items was 0.77. Similar analyses to those described above
were conducted for the trauma history questions and
PTSD diagnosis (women with PTSD diagnosis n = 58;
women without PTSD diagnosis n = 30). Here, significant
relationships between the trauma history screening ques-
tions and PTSD diagnosis were found using the count
method for the number of trauma history items endorsed.
The predictive value of PTSD diagnosis increased with the
number of trauma questions endorsed. For example,
women who reported 4 or more trauma screen items were
likely to have a PTSD diagnosis (sensitivity 78%, specifi-
city 53%). The false positive rate was 24%. The predictive
values of PTSD diagnosis for women who endorsed 4, 5,
or all 6 screening items are presented in Table 3. The area
under the ROC curves for these tests are modest, all under
0.70.
Interpersonal violence history and mental health 
symptoms in combination
At least 1 of the interpersonal violence history items was
endorsed on ninety-seven percent (85 of 88) of the
screens. Fifty-seven women (67%) reported experiencing
both childhood and adult interpersonal violence. Twenty-
four women (28%) experienced trauma only during
adulthood. Similar analyses to those described above for
validating the mental health screening items were con-
ducted within these strata. In the both groups, women
reporting both, childhood and adult interpersonal vio-
lence histories, the results paralleled those found among
the full validation sample.
Discussion
As expected, this sample of women entering substance
abuse treatment programs reported high rates of co-occur-
ring mental health symptoms, interpersonal violence
exposure, PTSD, and other life stressors. The validation of
the BCSFR Screen, with brief screening items on mental
Table 1: Demographic Characteristics of Screening and Validation Samples.
Screening Sample (N = 286) Validation Sample (N = 88) P-value
Age (mean, sd) 36.3 (8.1) 34.8 (7.7) 0.114
Race (n, %) <0.001
Hispanic 73 (26) 42(48)
White, non Hispanic 94 (33) 14 (16)
Black/African American, nonHispanic 99 (35) 29 (33)
Other/Multi Race, non Hispanic 20 (7) 3 (3)
Substance Abuse Treatment Modality <0.001
Methadone 164 (57) 9 (11)
Residential 48 (17) 55 (65)
Outpatient drug-free 74 (26) 21 (25)
Couldn't afford rent in past 2 years 146 (53) 52(60) 0.243
Couldn't obtain food in last year 105 (38) 40 (45) 0.199
Have children 247 (88) 81 (95) 0.043
Note: Validation sample size for Treatment modality was n = 85, for rent, n = 86, for children, n = 85. P-values for age, 2-sided Student's t-test and 
for remaining characteristics, Pearson Chi Square test. Statistical tests and degrees of freedom (df) are: Age, t-test = 1.58, df = 372; Race/ethnicity, 
Chi Square = 18.95 df = 3; Substance abuse modality, Chi Square 84.96, 2 df; Rent; Food; Children, Chi Square respectively = 1.36; 1.65; 4.08; df = 1.Page 5 of 9
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demonstrated a strong ability to predict PTSD but no
other major psychiatric disorders. The six interpersonal
violence history questions provide substance abuse coun-
selors with a strongly predictive marker for PTSD among
the women they work with in a simple and easy to admin-
ister battery of questions. The questions also give the sub-
stance abuse counselor relevant clinical history.
Mental health symptoms assessed on the BCSFR Screen
did not add predictive power to determine which women
entering substance abuse treatment have a co-occurring
psychiatric diagnosis as confirmed by an independent
clinical assessment. This finding is consistent with pub-
lished literature on the lack of sensitivity of a 2-question
dichotomous screener for depression from the PRIME-
MD [51]. Other researchers have found good test charac-
teristics to 2 similar questions on depressive symptoms
that were modified by using 4 answer choices ("not at all,"
"several days," "more than half the days," and "nearly
every day," scored as 0, 1, 2, and 3, respectively) [52]. This
could be considered in future studies of mental health
symptom screening. The K6 questions [26] to discrimi-
nate serious mental illness should also be tested in sub-
stance abuse treatment settings.
Despite lack of predictive value for depression, bipolar
disorder, and anxiety disorder, use of these types of
screening questions may add important value to the sub-
stance abuse intake process for a number of reasons. First,
Table 2: Screening Results of Women in Substance Abuse Treatment (N = 390).
Screening Sample 
N = 286 (n, %)
Validation sample 
N = 88 (n, %)
P-Value
In the past 30 days have you felt sad, blue, DEPRESSED or lost interest in things you usually 
cared about or enjoyed?
229 (81) 74(85) .413
In the past 30 days have you been bothered by ANXIOUS thoughts and feelings to the point 
that it made it hard to do your regular activities?
187(67) 64(74) .287
In the past 30 days have you had thoughts about HURTING YOURSELF or killing yourself or 
others?
46 (17) 16 (18) .709
In the past 30 days have you been BOTHERED BY THOUGHTS that interrupted you and that 
you had difficulty controlling?
141 (51) 50 (57) .285
Any Mental Health Symptoms 249 (89) 81 (92) .402
Have you ever been in a relationship where your partner has PUSHED or slapped you? 236 (83) 74 (84) .827
Have you ever been in a relationship where your partner has THREATENED you with 
violence?
213 (75) 76 (86) .025
Have you ever been in a relationship where your partner has thrown, BROKEN and punched 
things?
229 (81) 76 (86) .293
Any Intimate Partner Violence 251 (88) 82 (93) .199
Has anyone ever used FORCE or the threat of force to have sex with you against your will? 180 (65) 62 (71) .262
Any Sexual Assault 197 (70) 65 (75) .383
Before you were 13, was there any time when you were PUNCHED, kicked, choked, or 
received a more serious physical punishment from a parent or other adult?
125 (45) 45 (52) .221
Before you were 13 did anyone ever TOUCH you in a sexual way or make you touch them in 
a way you did not want them to?
140 (50) 49 (58) .196
Any Childhood Abuse 170 (60) 60 (70) .097
INDEPENDENT DIAGNOSTIC ASSESSMENTS (n, %)
Depressive Disorder 56 (64)
Bipolar Disorder 23 (26)
Anxiety Disorder 19 (22)
PTSD 58 (66)
Note: Any sexual assault summary combines items regarding force and touching. P-values are for Pearson Chi-square test of significance with 1 
degree of freedom; In validation sample, one observation was missing for mental health symptom items, one to three were missing for abuse and 
sexual assault items. In screening sample, 4–10 observations were missing for mental health items and 2–8 for abuse and sexual assault items.Page 6 of 9
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these symptoms, which was important to the women
seeking care. For example, 17% of the women in this
study reported suicidal ideation in the past 30 days. Men-
tal health symptoms are also important predictors of sub-
stance abuse treatment outcomes [1,19-21,23-25]. In
addition, asking these types of questions combined with
training raises awareness among members of the sub-
stance abuse treatment team about the need to incorpo-
rate mental health and trauma factors into treatment
planning. Strengthening the sensitivity through more
answer choices (see above) might improve the discrimina-
tory function while maintaining a simple and user-
friendly screening tool.
The strengths of our study include the ability to generalize
findings to clinical substance abuse programs, the
straightforward nature of the BCSFR screening questions,
and instrument validation in a substance abuse treatment
population. The input of different constituencies into the
development of the BCSFR Screen is also novel, as most of
the other PTSD and mental health screening instruments
were developed solely by research personnel and profes-
sionals. Client representatives and practicing substance
abuse counselors were instrumental in the development
of our entire screen, including instructions and layout of
the interview instrument. While validation of the Spanish
version of the instrument was limited by the small sample
size, another strength of the current study was testing in
both Spanish and English; other instruments are available
only in English (Spanish version available from Dr. Hort-
ensia Amaro). Study limitations include the criterion
measure – a semi-structured interview by a single mental
health professional. Use of an instrument such as the
SCID would have strengthened the validation [28]. How-
ever, the direction of any theoretical bias is not known
because the interviews were conducted in standard fash-
ion by an impartial clinician without knowledge of the
prior screening results. In addition, this study does not
discern the possible effects of withdrawal/early recovery.
Screening results at admission may reflect inflated depres-
sion and anxiety scores due to the combination of physi-
ological and psychological withdrawal as well as fears and
anxieties about the treatment process and its impact on
self, children, and other relationships. Future work should
explore the implications of these influences on mental
health status for appropriate clinical care.
Conclusion
Given the high prevalence of co-morbid mental health
disorders and distress among adults in publicly funded
substance abuse treatment, front-line treatment staff must
have resources to quickly assess the level of need of their
clients. Few such resources exist and more work is needed
to develop a tool available to front-line treatment staff to
help them identify which clients should be referred for
further mental health evaluation. We have developed and
tested a brief screen for mental health symptoms, expo-
sure to interpersonal violence, and other social stressors.
The tool, brief and easy-to-use, demonstrates good test
characteristics for predicting active PTSD but is unable to
predict other diagnoses. Mental health symptom ques-
tions might be modified in the future in order to improve
predictive value for these other mental health diagnoses.
This work is a first step toward improving the ability of
front-line staff in substance abuse treatment to identify
clients who might benefit from diagnostic assessment and
referral for mental health services. Future work should
focus on filling this gap in resources available to substance
abuse treatment staff.
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